Valeo Financial Advisors, LLC Abbott Laboratories Transaction History

Valeo Financial Advisors, LLC

$3.81 Billion
Q3 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 30,982 shares of ABT stock, worth $3.65 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

30,982

Previous 31,917 2.93%

Holding current value

$3.65 Million

Previous $3.32 Million 6.51%

% of portfolio

0.09%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $93,565 - $110,451	-935 Reduced 2.93%	30,982 $3.53 Million
Q2 2024 Jul 10, 2024	BUY	$100.73 - $112.44 $117,954 - $131,667	1,171 Added 3.81%	31,917 $3.32 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $14,237 - $15,724	-130 Reduced 0.42%	30,746 $3.49 Million
Q1 2024 Apr 19, 2024	BUY	$109.52 - $120.96 $34,827 - $38,465	318 Added 1.04%	30,876 $3.51 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $589,572 - $721,684	6,537 Added 27.21%	30,558 $3.36 Million
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $175,393 - $210,442	-1,836 Reduced 7.1%	24,021 $2.33 Million
Q2 2023 Jul 14, 2023	SELL	$100.78 - $112.29 $54,320 - $60,524	-539 Reduced 2.04%	25,857 $2.82 Million
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $172,410 - $202,937	1,780 Added 7.23%	26,396 $2.67 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $33,271 - $39,032	-350 Reduced 1.4%	24,616 $2.7 Million
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $435,420 - $504,135	4,500 Added 21.99%	24,966 $2.42 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $336,831 - $407,121	-3,300 Reduced 13.89%	20,466 $2.22 Million
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $356,084 - $434,221	3,123 Added 15.13%	23,766 $2.81 Million
Q4 2021 Jan 07, 2022	SELL	$115.53 - $141.46 $153,539 - $188,000	-1,329 Reduced 6.05%	20,643 $2.91 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $227,020 - $251,150	1,946 Added 9.72%	21,972 $2.6 Million
Q2 2021 Jul 22, 2021	SELL	$105.79 - $124.53 $866,631 - $1.02 Million	-8,192 Reduced 29.03%	20,026 $2.32 Million
Q1 2021 Apr 12, 2021	BUY	$108.84 - $128.23 $31,672 - $37,314	291 Added 1.04%	28,218 $3.38 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $933,450 - $1.02 Million	8,890 Added 46.7%	27,927 $3.06 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $60,115 - $73,006	-656 Reduced 3.33%	19,037 $2.07 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $22,894 - $29,302	-299 Reduced 1.5%	19,693 $1.8 Million
Q1 2020 Apr 13, 2020	SELL	$62.82 - $91.86 $95,926 - $140,270	-1,527 Reduced 7.1%	19,992 $1.72 Million
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $97,195 - $108,201	1,238 Added 6.1%	21,519 $1.87 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $151,158 - $163,902	-1,847 Reduced 8.35%	20,281 $1.7 Million
Q2 2019 Jul 10, 2019	BUY	$72.88 - $85.0 $20,479 - $23,885	281 Added 1.29%	22,128 $1.86 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $79,000 - $95,511	1,193 Added 5.78%	21,847 $1.75 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $2,294 - $2,599	-35 Reduced 0.17%	20,654 $1.49 Million
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $140,349 - $169,314	2,308 Added 12.56%	20,689 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $105,640 - $116,595	1,835 Added 11.09%	18,381 $1.17 Million
Q1 2018 Apr 12, 2018	SELL	$56.27 - $63.62 $90,763 - $102,619	-1,613 Reduced 8.88%	16,546 $991,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $10,252 - $10,976	191 Added 1.06%	18,159 $1.04 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $863,542 - $963,803	17,968	17,968 $959,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Abbott Laboratories Transaction History